辛伐他汀对大鼠心肌细胞肥大及蛋白激酶B表达的影响

Effects of Simvastatin on Cardiomyocytes Hypertrophy and Protein Kinase B Expression

  • 摘要: 目的观察辛伐他汀对血清诱导培养大鼠心肌细胞肥大的影响,探讨磷脂酰肌醇3激酶(PI3K)/蛋白激酶B(PKB)途径在辛伐他汀调控心肌细胞肥大中的信号转导作用。方法以培养的新生SpragueDawley(SD)大鼠心肌细胞为实验模型,应用图像分析系统测定心肌细胞表面积,3H亮氨酸掺入法测定心肌细胞蛋白合成速率,逆转录聚合酶链式反应(RTPCR)检测心钠素(ANP)mRNA表达,RTPCR和蛋白免疫印迹法(Westernblot)检测PKB的mRNA和蛋白表达水平。结果(1)15%血清组干预24h后心肌细胞表面积(1611.16±160.75)μm2显著高于无血清对照组(538.04±118.60)μm2,并有统计学意义(P<0.01);给予辛伐他汀和血清共同干预后,随着辛伐他汀浓度的增加,心肌细胞表面积呈递减趋势,其中10-5mol/L和10-6mol/L组分别为(799.84±167.70)μm2和(1076.88±199.28)μm2,均显著低于血清组(P<0.01)。(2)在15%血清刺激后,心肌细胞3H亮氨酸掺入率为(2360±106)计数/min·孔,明显高于无血清对照组(1305±92)计数/min·孔,并有统计学意义(P<0.01);10-5和10-6mol/L辛伐他汀组3H亮氨酸掺入率分别为(1707±101)计数/min·孔和(1962±125)计数/min·孔,均较血清组明显降低(P<0.01)。(3)随着辛伐他汀浓度的增加,心肌细胞ANP的mRNA表达水平逐渐降低,其中10-5和10-6mol/L辛伐他汀组分别为0.29±0.03和0.40±0.03,与单纯血清干预组(0.60±0.03)比较明显降低,差异非常显著(P<0.01)。(4)心肌细胞PKB的mRNA和蛋白表达水平均随辛伐他汀浓度的增加而呈递减趋势,其中10-5、10-6mol/L辛伐他汀组PKBmRNA表达水平为0.28±0.02和0.36±0.03,明显低于血清干预组(0.51±0.03),并有统计学意义(P<0.01)。上述两组PKB蛋白表达水平分别为42.41±2.83和45.68±3.43,也较血清组(60.80±3.49)显著降低(P<0.01)。结论辛伐他汀能够抑制血清诱导的心肌细胞肥大,PKB表达水平下调可能是其分子生物学机制之一。

     

    Abstract: ObjectiveTo study the effects of simvastatin on the hypertrophy of cultured rat cardiac myocytes induced by serum and investigate the role of phosphoinositide 3-kinase(PI3K)/protein kinase B(PKB).MethodsImage analysis system was used to measure cell surface area.Protein synthesis of myocytes derived from cultured neonatal Sprague-Dawley(SD) was measured via -leucine incorporation.The expression level of mRNA of atrial natriuretic peptide(ANP)in myocytes was determined with reverse transcription polymerase chain reaction(RT-PCR).RT-PCR and Western blot were used to study the mRNA and protein expression level of PKB.Rlllesults(1)Cardiac myocytes surface area was lowered in serum-free group than in 15% serum group (538.04±118.60)μm 2 vs (1611.16±160.75)μm 2(P<0.01).Simvastatin decreased cell surface area in a concentration dependent manner.Cell surface area in 10 -5 and 10 -6 mol/L simvastatin groups were (799.84±167.70)μm 2 and (1076.88±199.28)μm 2, which were both significantly lower than that in serum group(both P<0.01).(2) Incorporation rate of serum-free group was (1305±92)cpm/well .It was much higher in serum group(2369±106)cpm/well than that in serum-free group(P<0.01).Incorporation rate of -leucine in 10 -5 and 10 -6 mol/L simvastatin groups were (1 707±101)cpm/well and (1 962±125)cpm/well, respectively, which were both lower than that in serum group(P<0.01).(3)With the increase of simvastatin concentrations, the ANP mRNA expression was decreased gradually compared with that of serum group(0.60±0.03).The level of ANP mRNA in 10 -5 and 10 -6 mol/L simvastatin groups were 0.29±0.03 and 0.40±0.03, which were both lower than that in serum group(P<0.01).(4)Simvastatin inhibited the expression of PKB mRNA induced by serum in a concentration dependent manner.The PKB mRNA expression level in serum group was 0.51±0.03.The PKB mRNA level in 10 -5 and 10 -6 mol/L simvastatin groups were 0.28±0.02 and 0.36±0.03, respectively, which were both much lower than that of serum group(P<0.01).Similarly, compared with serum group(60.80±3.49), the protein level of PKB in 10 -5 and 10 -6 mol/L simvastatin groups (42.41±2.83 and 45.68±3.43) were also both significantly decreased(P<0.01).ConclusionSimvastatin inhibit the hypertrophy of cultured rat cardiac myocytes induced by serum.The mechanism might be related with the decrease of expression level of PKB.

     

/

返回文章
返回